JP2024001073A5 - - Google Patents

Download PDF

Info

Publication number
JP2024001073A5
JP2024001073A5 JP2023165289A JP2023165289A JP2024001073A5 JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5 JP 2023165289 A JP2023165289 A JP 2023165289A JP 2023165289 A JP2023165289 A JP 2023165289A JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023165289A
Other languages
English (en)
Japanese (ja)
Other versions
JP7849340B2 (ja
JP2024001073A (ja
Filing date
Publication date
Priority claimed from JP2020543460A external-priority patent/JP7358367B2/ja
Application filed filed Critical
Priority to JP2023165289A priority Critical patent/JP7849340B2/ja
Publication of JP2024001073A publication Critical patent/JP2024001073A/ja
Publication of JP2024001073A5 publication Critical patent/JP2024001073A5/ja
Application granted granted Critical
Publication of JP7849340B2 publication Critical patent/JP7849340B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023165289A 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用 Active JP7849340B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023165289A JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020543460A JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用
PCT/US2017/058036 WO2019083506A1 (en) 2017-10-24 2017-10-24 ANTI-GLYCO-MUC1 ANTIBODIES AND USES THEREOF
JP2023165289A JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020543460A Division JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用

Publications (3)

Publication Number Publication Date
JP2024001073A JP2024001073A (ja) 2024-01-09
JP2024001073A5 true JP2024001073A5 (enExample) 2024-04-24
JP7849340B2 JP7849340B2 (ja) 2026-04-21

Family

ID=66247577

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020543460A Active JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用
JP2023165289A Active JP7849340B2 (ja) 2017-10-24 2023-09-27 抗グリコmuc1抗体およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020543460A Active JP7358367B2 (ja) 2017-10-24 2017-10-24 抗グリコmuc1抗体およびその使用

Country Status (10)

Country Link
EP (1) EP3700936A4 (enExample)
JP (2) JP7358367B2 (enExample)
KR (2) KR102832078B1 (enExample)
CN (1) CN111479828B (enExample)
AU (1) AU2017436815B2 (enExample)
BR (1) BR112020008001A2 (enExample)
CA (1) CA3078812A1 (enExample)
IL (1) IL274202A (enExample)
MX (1) MX2020004220A (enExample)
WO (1) WO2019083506A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102832078B1 (ko) * 2017-10-24 2025-07-08 고 테라퓨틱스, 인크. 항-글리코-muc1 항체 및 이의 용도
CN116322770A (zh) * 2020-07-31 2023-06-23 R·P·舍勒科技有限责任公司 对粘蛋白-1特异的抗体及其使用方法
US20250129180A1 (en) * 2021-08-27 2025-04-24 Peptron, Inc. Novel anti-muc1 antibody and use thereof
WO2023121448A1 (en) * 2021-12-21 2023-06-29 Merus N.V. Binding domains against cancer-associated muc1
CN114796498A (zh) * 2022-01-27 2022-07-29 中国农业大学 抑制muc1糖基化修饰的物质在提高乳腺癌细胞对抗乳腺癌药物的敏感度中的应用
WO2024213106A1 (zh) * 2023-04-13 2024-10-17 江苏恒瑞医药股份有限公司 特异性结合egfr和muc1的抗原结合分子、其药物偶联物及其医药用途
WO2026046336A1 (zh) * 2024-08-29 2026-03-05 江苏恒瑞医药股份有限公司 Trop2/MUC1结合分子及医药用途
WO2026132383A2 (en) 2024-12-20 2026-06-25 F. Hoffmann-La Roche Ag ANTIBODIES BINDING TO Tn-MUC-1
WO2026132145A1 (en) 2024-12-20 2026-06-25 F. Hoffmann-La Roche Ag Antibodies binding to tn-muc-1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075110A2 (en) * 2000-03-30 2001-10-11 Dyax Corp. Mucin-1 specific binding members and methods of use thereof
DE10303664A1 (de) * 2003-01-23 2004-08-12 Nemod Immuntherapie Ag Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
JP2010505775A (ja) * 2006-10-04 2010-02-25 クーベンハヴンス・ユニヴェルシテット Muc1に対する癌特異的な免疫反応の産生及び癌特異的muc1抗体
EP2014302A1 (en) * 2007-07-12 2009-01-14 Institut Curie An antibody specific for the Tn antigen for the treatment of cancer
CA2707689A1 (en) * 2007-12-05 2009-06-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
CA2741798A1 (en) * 2008-10-28 2010-05-06 Shionogi & Co., Ltd. Anti-muc1 antibody
EP2281844A1 (en) * 2009-07-31 2011-02-09 Glycotope GmbH MUC 1 antibodies
US10208125B2 (en) * 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
WO2015120180A1 (en) * 2014-02-05 2015-08-13 The University Of Chicago Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants
JP6476170B2 (ja) * 2014-04-28 2019-03-06 医化学創薬株式会社 抗muc1抗体又はその抗原結合性断片及びその用途
KR102832078B1 (ko) * 2017-10-24 2025-07-08 고 테라퓨틱스, 인크. 항-글리코-muc1 항체 및 이의 용도

Similar Documents

Publication Publication Date Title
EP4039707A1 (en) Cd3-targeting antibody, bispecific antibody and use thereof
EP3353213B1 (en) Anti-mesothelin antibody and composition comprising the same
JP2022512132A5 (enExample)
JP2019116474A5 (enExample)
AU2020352382A1 (en) Anti-human claudin 18.2 antibody and application thereof
JP2021510710A5 (enExample)
JP2019527553A5 (enExample)
JP2023549537A5 (enExample)
JP2021503455A5 (enExample)
AU2018218753A1 (en) Anti-GPRC5D antibody and molecule containing same
JP2023540526A5 (enExample)
JP2013502913A5 (enExample)
KR20220111308A (ko) 인간화 cldn18.2 항체
JP7821159B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
AU2017379382A1 (en) Anti-CD3 Antibody and Molecules Comprising the Antibody
CN115052895A (zh) 抗SIRPα抗体及其用途
JP2023543493A5 (enExample)
EP4155320A1 (en) Anti-b7h4 antibody, and bispecific antibody and use thereof
JP2021529524A5 (enExample)
TW202241944A (zh) 新穎的抗gremlin1抗體
JP2020522488A5 (enExample)
CN106243223B (zh) 抗人pdl1抗体及其用途
JP2024515560A5 (enExample)
CN113574069A (zh) 抗pd-l1抗体及其用途
JP2022540610A5 (enExample)